June 15, 2022
A recent study showed that patients with atopic dermatitis have a higher prevalence of infertility, highlighting the need for clinicians to be wary of this increased risk and improve the care and management of this patient population.
June 14, 2022
Amy Paller, MD, sits down to answer important questions on the FDA approval of dupilumab for patients aged 6 months to 5 years.
June 13, 2022
Isotretinoin prescriptions are a challenging endeavor, requiring collaboration between providers, office administrative staff, pharmacists, insurance companies, and laboratory facilities.
June 08, 2022
Sanofi and Regeneron Pharmaceuticals, Inc announced the FDA approval of dupilumab. It is now the first biologic medicine for children from 6 months to 5 years old with moderate to severe atopic dermatitis.
June 06, 2022
Investigators explore the effectiveness of new combination therapies to address the multifactorial pathophysiology of acne vulgaris.
June 02, 2022
Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
May 31, 2022
Learn to discern the best pain-mitigation strategies for each patient, based on research and personal experience.
May 26, 2022
Verrica received a Complete Response Letter from the FDA regarding their New Drug Application for the topical molluscum contagiosum treatment, VP-102.
May 23, 2022
A single lesson made an impact on high school students' knowledge and behavior when it came to sun protection.
May 18, 2022
Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course for your patients and their families on sun protection, which can go a long way in preventing skin damage and disorders due to the sun.